News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
The impact of post-remission G-CSF use in the phase 3 studies of venetoclax in AML
Courtney D. DiNardo/faculty.mdanderson.org
Dec 6, 2024, 15:22

The impact of post-remission G-CSF use in the phase 3 studies of venetoclax in AML

Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on X:

“The impact of post-remission G-CSF use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed AML |American Journal of Hematology | Blood Research Journal | Wiley Online Library.”

The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia

Authors: Courtney D. DiNardo, Keith W. Pratz, Panayiotis Panayiotidis, Xudong Wei, Vladimir Vorobyev, Árpád Illés, Inho Kim, Vladimir Ivanov, Grace Ku, Catherine L. Miller, Meng Zhang, Fernando Tatsch, Jalaja Potluri, Xenia Schmidt, Christian Récher

venetoclax

Árpád Illés cancer Catherine L. Miller Christian Récher Courtney D. DiNardo Fernando Tatsch Grace Ku Inho Kim Jalaja Potluri Keith W. Pratz Meng Zhang OncoDaily Oncology Panayiotis Panayiotidis venetoclax Vladimir Ivanov Vladimir Vorobyev Xenia Schmidt Xudong Wei
Special Coverage
Societies
Mar 30, 2025, 07:54
Our work touched 111 million lives, providing critical support to people facing cancer - American Cancer Society
Blog
Mar 30, 2025, 07:43
Salma Najem: ESO Professorship 2025 will be held at the National Institute of Oncology in Rabat
Blog
Mar 30, 2025, 07:23
Most childhood cancer survivors will experience late effects - Childhood Cancer International
Blog
Mar 30, 2025, 06:28
Anirban Maitra: Pancreatic cancer and glioblastoma deserve more investment, not funding cuts
Insight
Mar 30, 2025, 06:07
Lung Cancer Network Malaysia (LCNM) has introduced an advanced AI-powered liquid biopsy
Blog
Mar 30, 2025, 05:22
Cures in Crisis: What Gutting NIH Research Means for Americans with Cancer, Alzheimer’s and Other Diseases - American Association for Cancer Research
Blog
Mar 30, 2025, 05:11
Raphael E. Cuomo: How evidence from cancer epidemiology can inform personal and population-level strategies to reduce cancer risk
Blog
Mar 30, 2025, 04:59
Mohamed Emam Sobeih: Excited to share my poster in ELCC 2025
Science
Mar 30, 2025, 04:49
Andreas Charalambous: The need for Comprehensive Digital Tools in better understanding and managing patients’ nutritional needs
Blog
Mar 30, 2025, 04:41
Crystal Denlinger: The latest advances in cancer care from national multidisciplinary experts at NCCN2025
Blog
Mar 30, 2025, 04:24
Robin Zon: Congratulations to FASCO recipients for their extraordinary volunteer service, dedication, and commitment to ASCO
Blog
Mar 30, 2025, 04:13
Brian Alexander: Excited to join the board of MassBio